Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
09/04/1996 | EP0729473A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
09/04/1996 | EP0729300A1 Novel fas protein and methods of use thereof |
09/04/1996 | EP0636031B1 Vaccine adjuvant |
09/04/1996 | EP0506884B1 Method of delivering molecules into eukaryotic cells |
09/04/1996 | EP0491014B1 Sm-D ANTIGEN PEPTIDES AND THEIR USE, IN PARTICULAR, FOR THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS |
09/04/1996 | EP0458878B1 Monoclonal antibody to novel antigen associated with human tumors |
09/04/1996 | CN1130405A Monoclonal antibody that induces apoptosis |
09/04/1996 | CN1130193A Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor (EGF-R) and its diagnosis and therapeutical use |
09/03/1996 | US5552541 Haptenic probes for detecting capture polynucleotides |
09/03/1996 | US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
09/03/1996 | US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy |
09/03/1996 | US5552300 T cell antigen receptor V region proteins and methods of preparation thereof |
09/03/1996 | US5552293 Tumor antigen specific antibody |
09/03/1996 | US5552286 Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
09/03/1996 | US5552284 Detection of interleukin-8 receptors by nudeic acid hybridization |
09/03/1996 | US5552146 Methods and compositions relating to useful antigens of Moraxella catarrhalis |
09/03/1996 | US5552144 Immunogenic shiga-like toxin II variant mutants |
09/03/1996 | US5552143 Recombinant cytomegalovirus vaccine |
09/03/1996 | US5552142 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
09/03/1996 | US5552141 Polymeric immunological adjuvants |
09/03/1996 | US5552086 Gold and silver on polystyrene, useful for raman spectroscopy and flow cytometry, interlayer of aminodextran |
09/03/1996 | CA1338570C Endowing cells with antibody specificity |
09/02/1996 | CA2170839A1 Bacterial preparations, method for producing same, and their use as vaccines |
08/29/1996 | WO1996026288A1 A method for the isolation and purification of lipid cell-wall components |
08/29/1996 | WO1996026285A2 Methods and compositions for administering gene therapy vectors |
08/29/1996 | WO1996026284A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
08/29/1996 | WO1996026277A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
08/29/1996 | WO1996026276A1 SecA GENE OF MYCOBACTERIUM TUBERCULOSIS AND RELATED METHODS AND COMPOSITIONS |
08/29/1996 | WO1996026275A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
08/29/1996 | WO1996026274A1 Antagonists of interleukin-15 |
08/29/1996 | WO1996026272A1 Prostate-specific membrane antigen and uses thereof |
08/29/1996 | WO1996026271A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof |
08/29/1996 | WO1996026214A1 Isolated nonapeptides presented by hla molecules, and uses thereof |
08/29/1996 | WO1996025953A1 Redirection of cellular immunity by receptor chimeras |
08/29/1996 | WO1996025951A1 Gel form of a vaccine |
08/29/1996 | WO1996025945A1 ISOFORMS OF HUMAN INTERLEUKIN-1β CONVERTING ENZYME AND METHODS OF USING THE SAME |
08/29/1996 | WO1996025942A1 Cochleate phospholipids in drug delivery |
08/29/1996 | WO1996025941A1 Modulators of regulatory proteins |
08/29/1996 | WO1996019580A3 Telomerase protein component |
08/29/1996 | WO1996019578A3 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN ahpCF OPERON |
08/29/1996 | WO1996009391A3 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 |
08/29/1996 | DE19506483A1 Antitumour vaccines |
08/29/1996 | CA2213610A1 Ingap protein involved in pancreatic islet neogenesis |
08/29/1996 | CA2213484A1 Modulators of regulatory proteins |
08/29/1996 | CA2213451A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof |
08/29/1996 | CA2213439A1 Methods and compositions for administering gene therapy vectors |
08/29/1996 | CA2213428A1 A method for the isolation and purification of lipid cell-wall components |
08/29/1996 | CA2213337A1 Isolated nonapeptides presented by hla molecules, and uses thereof |
08/29/1996 | CA2212870A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
08/29/1996 | CA2212846A1 Prostate-specific membrane antigen and uses thereof |
08/29/1996 | CA2211995A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
08/29/1996 | CA2211541A1 Isoforms of human interleukin-1.beta. converting enzyme and methods of using the same |
08/29/1996 | CA2211435A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
08/28/1996 | EP0728842A2 Live recombinant avian vaccine based on an avianherpes virus, against Gumboro disease |
08/28/1996 | EP0728764A1 Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide |
08/28/1996 | EP0728216A1 Detection of alzheimer's disease and other diseases using an improved photoaffinity labeling method |
08/28/1996 | EP0728215A1 METHOD OF BINDING MATERIAL TO THE $g(b)-AMYLOID PEPTIDE |
08/28/1996 | EP0728209A1 Endothelin-converting enzyme |
08/28/1996 | EP0728203A1 Analogous peptides of the internal image of a viral protein |
08/28/1996 | EP0728200A1 Haemophilus transferrin receptor genes |
08/28/1996 | EP0728148A1 Improved immunogenic compositions against human gastrin 17 |
08/28/1996 | EP0728146A1 Conotoxin peptides |
08/28/1996 | EP0728143A1 Oncoprotein protein kinase |
08/28/1996 | EP0728142A1 Novel antler-derived bone growth factors |
08/28/1996 | EP0728017A1 Treatment of bacterially-induced inflammatory diseases |
08/28/1996 | EP0728015A1 Combinatorial polypeptide antigens |
08/28/1996 | EP0728014A1 Vaccines expressed in plants |
08/28/1996 | EP0728013A1 Compositions and method for stimulating antibody release by b lymphocytes |
08/28/1996 | EP0592454B1 Production of vaccines |
08/28/1996 | EP0571407B1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family |
08/28/1996 | EP0406297B1 Medical use of neuropeptide Antagonist G |
08/28/1996 | CN1129984A Immunoassay for soluble fibrin polymers |
08/27/1996 | US5550223 Lipoprotein I (ompi) of pseudomonas aeruginosa |
08/27/1996 | US5550155 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures |
08/27/1996 | US5550052 Useful for detection of lav antibodies in human sera |
08/27/1996 | US5550051 Avian embryo cell aggregate biomass for producing virus/virus antigen and method for producing virus/virus antigen |
08/27/1996 | US5550049 Useful as insecticides and arachnicidic agents |
08/27/1996 | US5550043 Expression of heterologous proteins in Drosophila cells |
08/27/1996 | US5550019 Methods of identifying compounds which alter apoptosis |
08/27/1996 | US5550017 Anti-paramyxovirus screening method and vaccine |
08/27/1996 | US5549899 Culture product of strain of giardia lamblia and an adjuvant, used to treat intestinal protozoal infections in canine and feline species |
08/27/1996 | US5549898 Parasiticides |
08/27/1996 | US5549897 High molecular weight surface proteins of non-typeable haemophilus |
08/27/1996 | US5549896 For prophylaxis, diagnosis |
08/22/1996 | WO1996025664A1 Immunotherapy screening, prognosis, and treatment methods and compositions |
08/22/1996 | WO1996025508A1 Nucleic acid-containing composition, preparation and use thereof |
08/22/1996 | WO1996025497A1 New chemokines expressed in pancreas |
08/22/1996 | WO1996025494A1 Transcription factor - e2f-5 |
08/22/1996 | WO1996025493A1 Multiple-tumor aberrant growth genes |
08/22/1996 | WO1996025435A1 MONOCLONAL ANTIBODY SPECIFIC FOR βA4 PEPTIDE |
08/22/1996 | WO1996025430A1 Helicobacter pylori antigen |
08/22/1996 | WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
08/22/1996 | WO1996025422A1 Keratinocyte growth factor-2 |
08/22/1996 | WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY |
08/22/1996 | WO1996025177A1 Medicinal combination useful for in vivo exogenic transfection and expression |
08/22/1996 | WO1996025146A1 Gram negative bacterial infection vaccine |
08/22/1996 | WO1996019498A3 T cell stimulating protein of pestivirus |
08/22/1996 | CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
08/22/1996 | CA2213237A1 Multiple-tumor aberrant growth genes |
08/22/1996 | CA2212952A1 Helicobacter pylori antigen |